Zurueck zur Suche

Reporte zur Charge P100584033

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 1 TN 1

VAERS 2694957

SEQIRUS, INC. · INFLUENZA (SEASONAL) (AFLURIA QUADRIVALENT) · Charge P100584033

moderat
Staat
TX
Alter
29,0
Geschlecht
F
Eingang
12.10.2023
Impfdatum
12.10.2023
Beginn
12.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site paraesthesia Pharyngeal paraesthesia Somnolence

Symptomtext

Patient came to get her seasonal flu shot. Patient states she has no NKA and is the first time to get the Flu shot. Patient received the vaccine approx. 8:55 a.m. Patient states she started experiencing tingling in the throat and at the injection site approximately 15 minutes later (9:10 a.m). after administration of vaccine. I contacted Medical Director for recommendations. Dr. recommends patient get 25 mg of Bendadryl. Patient received 25 mg(10 mls) liquid Benadryl with no complications noted. Vital Signs stable at B/P 102/70, pulse 77, SpO2 100%, Lungs clear to auscultation to all lobes. Re-checked symptoms 15 mins later (9:25 a.m.) patient states she still feels some swelling to back of neck. Dr. recommends to administer another 25mg (10mls) of Bendadryl. Patient took medication with no complications. At 9:45 a.m. patient states she feels better, but drowsy. Her husband was called to drive her to clinic to get checked by Dr. I instructed patient to go get checked at the clinic. Patient verbalized understanding. Dr. aware patient was on her way. I placed a follow up call at 11:21 a.m. to see how patient was doing. She states she did not go the clinic to get checked and went home to rest. She states she is feeling better. She states she does not have no respiratory distress, no swelling, no wheezing and no other s/s. Patient was instructed again to go to the ER if symptoms worsen. She verbalized understanding. Dr. was notified and aware of patient conversation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site paraesthesia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None stated
Vorgeschichte
None Stated
Andere Medikamente
None stated
Allergien
No
Vorherige Impfungen
-

VAERS 2703989

SEQIRUS, INC. · INFLUENZA (SEASONAL) (AFLURIA QUADRIVALENT) · Charge P100584033

mild
Staat
TN
Alter
53,0
Geschlecht
M
Eingang
27.10.2023
Impfdatum
24.10.2023
Beginn
25.10.2023
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site pruritus Injection site swelling

Symptomtext

injection area became red, swollen, and itching to patient ~ 12-24 hours after injection recommended benadryl and ibuprofen for both redness, swelling, and itching patient did state that redness and swelling had started to dissipate after 48 hour mark from injection

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
no known allergies
Vorherige Impfungen
-